Aditxt Introduces AditxtScore™ for COVID-19 and Announces the Completion of Validation Studies by Stanford Blood Center
August 06, 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Company Plans to file for an Emergency Use Authorization (EUA) and 510(k) Application in the Current Quarter (Q3, 2020) Loma Linda, CA, Aug. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...
Aditx Therapeutics Appoints Jeff Ramson, Wall Street Veteran and Founder of PCG Advisory as Senior Advisor, Capital Markets & Communications
August 03, 2020 08:00 ET
|
Aditx Therapeutics, Inc.
LOMA LINDA, CA, Aug. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specifically...
Founding Partner of Securities Law Firm Anthony L.G., Laura Anthony, Appointed to Aditx Therapeutics’ Board of Directors and Will Chair Its Governance Committee
July 24, 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Ms. Anthony and Her Legal Team have Represented Private and Public Finance Transactions in excess of $1 Billion Loma Linda, CA, July 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx...
Aditxt to Present at Zooming with LD
July 22, 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Presentation on Tuesday, July 28th at 11:00 AM ET Loma Linda, CA, July 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditx) (the “Company”) (Nasdaq: ADTX), a life...
Former CFO of BlackRock Capital Investment Corporation and AIG Capital Partners' Global Emerging Markets Group Corinne Pankovcin, Joins Aditx Therapeutics as Chief Financial Officer
July 21, 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Ms. Pankovcin has 30 Years of Public Company Financial Experience with World Class Organizations LOMA LINDA, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc....
CEO, CIO, and Senior Advisors of Aditxt Complete Conversion of ~$1.1 Million in Accrued Compensation into Restricted IPO Units
July 10, 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Loma Linda, CA, July 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specifically...
CORRECTION: Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering
July 06, 2020 16:46 ET
|
Aditx Therapeutics, Inc.
Trading on Nasdaq under Ticker “ADTX” This is a correction of the announcement. The number of Series A warrants and Series B warrants purchased by the underwriters in the over-allotment option has...
Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering
July 02, 2020 16:10 ET
|
Aditx Therapeutics, Inc.
Trading on Nasdaq under Ticker “ADTX” Loma Linda, CA, July 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company...
Aditx Therapeutics, Inc. (Aditxt) Announces Pricing of Initial Public Offering
June 30, 2020 09:49 ET
|
Aditx Therapeutics, Inc.
Will Trade on the Nasdaq Capital Market Under Ticker “ADTX” Loma Linda, CA, June 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (the “Company”) (Nasdaq: ADTX), a life...